Valos S.r.l. In Forma Abbreviata Va Los
Valos S.r.l. In Forma Abbreviata Va Los is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
A multi-center, open-label, uncontrolled, single-arm, extension study to determine the long-term safety and tolerability of oral lucerastat in adult subjects with Fabry disease.
Sponsor Idorsia Pharmaceuticals Ltd.
- Start (EU)
- Latest update
- Estimated end
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)
Sponsor PPM Services S.A.
- Start (EU)
- Latest update
- Estimated end
A long-term safety and efficacy study of N-Acetyl-GED-0507-34-LEVO gel 5%, in subjects with acne vulgaris (GEDACNE-LT)
Sponsor PPM Services S.A.
- Start (EU)
- Latest update
- Estimated end
A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-2)
Sponsor PPM Services S.A.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Valos S.r.l. In Forma Abbreviata Va Los?
The 2026-10-09 snapshot links Valos S.r.l. In Forma Abbreviata Va Los to 4 distinct CTIS trials. Recorded services include Statistical analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Valos S.r.l. In Forma Abbreviata Va Los?
The most frequently recorded therapeutic areas are Cardiology, Dermatology, Genetic and Congenital Disorders, Nephrology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Valos S.r.l. In Forma Abbreviata Va Los conducted?
The linked trials record locations in 8 countries, including Spain, Poland, France, Italy, Austria. These are trial locations, not confirmed office locations or countries where Valos S.r.l. In Forma Abbreviata Va Los delivered services.
What can this page tell me about Valos S.r.l. In Forma Abbreviata Va Los's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Valos S.r.l. In Forma Abbreviata Va Los. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Valos S.r.l. In Forma Abbreviata Va Los S.r.l.